To a standing-room only audience, two MWG agencies hosted a special UN General Assembly side event for Access Accelerated working to tackle non-communicable diseases around the world.
This week during the 72nd U.N. General Assembly in New York City, McCann Global Health in partnership with Weber Shandwick hosted an event for Access Accelerated, a collaborative commitment by 22 biopharmaceutical companies and partners, including the World Bank and the Union for International Cancer Control. The mission of Access Accelerated is to tackle the growing burden of non-communicable diseases (NCDs) in low and lower middle-income countries.
The event highlighted the progress the initiative has made-to-date since McCann Global Health, MRM//McCann and Weber Shandwick first partnered to launch Access Accelerated at the World Economic Forum in January.
In attendance were eight Access Accelerated member companies–Astellas, Bristol-Myers Squibb, Eisai, Merck KGaA, Pfizer, Roche, Sanofi and Shionogi–Her Royal Highness Dina Mired of Jordan, United Nations Foundation CEO and President Kathy Calvin. Throughout the evening, Access Accelerated reinforced its commitment to public-private partnerships while thoughtful and engaging representatives shared ideas on best approaches and lessons learned.
We are proud to play an integral leadership role in this important initiative as NCDs have become a global problem effecting countries, communities and citizens throughout the world.
Pictured, from left to right:
Gomathi Kaliappan, Project Lead, the Blue Tree Oncology Patient Support Program, Roche India
Dr. Chite Asirwa, Medical Co-Director, AMPATH Oncology and Hematology Program
Professor Angelica Samudio, Head of Hematology and Oncology, Asunction’s Hospital
Raj Kumar, Founding President and Editor-in-Chief, Devex
Dr. Ann Aerts, Head, Novartis Foundation
Dr. Susan Henshall, Program Director, C/Can 2025: City Cancer Challenge, UICC